Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting

Dermatologic Surgery

Volumn 38, Issue 4, 2012, Pages 570-584

  Wilson, Leslie S ^a,b   Pregenzer, Mark ^c   Basu, Rituparna ^d   Bertenthal, Daniel ^d   Torres, Jeanette ^e   Asgari, Maryam ^f   Chren, Mary Margaret ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^f Kaiser Permanente Northern California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CURETTAGE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRIVATE PRACTICE; SKIN BIOPSY; SKIN CANCER; SKIN SURGERY; TUMOR VOLUME;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEES AND CHARGES; FEMALE; HUMANS; MALE; PRIVATE PRACTICE; SKIN NEOPLASMS;

EID: 84859443897     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02231.x     Document Type: Article

References (38)

1. Rhee JS, Matthews BA, Neuburg M, Logan BR, et al. The Skin Cancer Index: clinical responsiveness and predictors of quality of life. Laryngoscope 2007;117:399-405. (Pubitemid 46407744)
2. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
3. Chren MM, Sahay AP, Sands LP, Maddock L, et al. Variation in care for nonmelanoma skin cancer in a private practice and a Veterans Affairs clinic. Med Care 2004;42:1019-26. (Pubitemid 39530798)
4. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Opthalmology 2004;111:631-6. (Pubitemid 38429659)
5. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5 year follow-up. Opthalmology 2004;111:631-6. (Pubitemid 38429659)
6. Smeets NWJ, Krekels GAM, Ostertag JU, Essers BAB, et al. Surgical excision versus Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766-72. (Pubitemid 39488061)
7. Vuyk HD, LPJF M. Mohs micrographic surgery for facial skin cancer. Clin Otolaryngol Allied Sci 2001;26:265-73. (Pubitemid 32955502)
8. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008;9:1149-56.
9. Do D. Mohs micrographic surgery for basal cell carcinoma of the face. Arch Dermatol 2009;145:1428-30.
10. Feldman S, Pearce DJ, Williford PM. Surgical decision making for basal-cell carcinoma of the face. Lancet Oncol 2008;9:1119-20.
11. Otley CC. Mohs' micrographic surgery for basal-cell carcinoma of the face. Lancet 2005;365:1226-7; author reply 7.
12. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Basal cell and squamous cell skin cancers. 2011. Accessed June 3, 2011. Available from: http://www.nccn.org/professionals/physicain-gls/pdf/nmsc. pdf. Accessed November 21, 2011.
13. AMA CPT. AMA CPT approves new site specific Mohs codes last minute fix to 2007 medicare fee schedule. Derm Coding Consult 2006; 5:1-8
14. Chren MM, Sahay AP, Bertenthal DS, Sen S, et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007;127:1351-7. (Pubitemid 46762993)
15. Clark FL, Sahay A, Bertenthal D, Maddock L, et al. Variation in care for recurrent nonmelanoma skin cancer in a University-based practice and a Veterans Affairs clinic. Arch Dermatol 2008;144:1148-52.
16. AMA CPT. AMA CPT approves new site specific Mohs codes. Derm Coding Consult 2006;5:1-8
17. Centers for Medicare and Medicaid Services. 2008 Medicare fee schedule. Washington, DC: US Government Printing Office, Office of the Federal Register; 2007. pp. 66254-5.
18. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons, 1987; pp. 1-75.
19. Ellis JI, Khrom T, Wong A, Gentile MO. Mohs math - where the error hides. BMC Dermatol 2006;7:1-11.
20. Kroger DH. Expert analysis from a meeting sponsored by the American Society for Mohs Surgery. San Diego: Internal Medicine News; 2010. pp. 1-2.
21. Murray L, editor. Red book. Montvale, NJ: Thomson Healthcare Inc; 2007.
22. Street JO, Caarroll RJ, Ruppert DA. Note on computing robust regression estimates via iteratively reweighted least squares. Am Stat 1988;42:152-4.
23. Buntin MB, Zaslavsky AM. Too muuch ado about two-part models and transformation? Comparing methods of modeling medicare expenditures J Health Econ 2004;23:525-42. (Pubitemid 38569537)
24. Bialy TL, Whalen J, Veledar E, Lafrenierie D, et al. Mohs micrographic surgery versus traditional surgical excision: a cost comparison analysis. Arch Dermatol 2004;140:736-42. (Pubitemid 38747292)
25. Cook Joel, A ZJ. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998;39:698-703.
26. John Chen G, Yelverton CB, Polisetty SS, Housman T, et al. Treatment patterns and cost of nonmelanoma skin cancer management. Dermatol Surg 2006;32:1266-71. (Pubitemid 44569999)
27. Essers B, Nieman F, Prins M, Smeets N, et al. Perceptions of facial aesthetics in surgical patients with basal cell carcinoma. J Eur Acad Dermatol Venereol 2007;21:1209-14. (Pubitemid 47423409)
28. Housman TS, Feldman SR, Williford PM, Fleisher AB Jr, et al. Skin cancer is among the most costly of all cancers to treat for the medicare population. J Am Acad Dermatol 2003;48:425-9. (Pubitemid 36337080)
29. Narayanan K, Hadid OH, EA B, editors. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. New York: John Wiley & Sons; 2009; pp.1-14 (Cochrane Review).
30. Welch ML, Anderson LL, Grabski WJ. Evaluation and management of nonmelanoma skin cancer: The military perspective. In: 9/18/09. hwmcdab-j-jssa, Thiers BH, editor. Dermatologic clinics. New York: W.B. Saunders Company; 1999. pp. 19-28.
31. Miller PK, Roenigk RK, Brodland DG, Randle HW. Cutaneous micrographic surgery: Mohs procedure. Mayo Clin Proc 1992;67:971-80.
32. Higashi MK, Veenstra DL, Langley PC. Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics 2004;22:83-94. (Pubitemid 38241495)
33. Lear W, Mittmann N, Barnes E, Breen D, et al. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg 2008;12:82-7.
34. Smeets NWJ, Kuijpers DIM, Nelemans P, Ostertag JU, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 2004;151:141-7. (Pubitemid 39061291)
35. Bentkover SH, Grande DM, Soto H, Kozlicak BA, et al. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg 2002;4:114-9.
36. Essers BA, Dirksen CD, Nieman FH, Smeets NW, et al. Costeffectiveness of Mohs Micrographic surgery versus surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006;142:187-94. (Pubitemid 43276530)
37. Essers BA, Dirksen CD, Prins MH. Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands. Dermatol Surg 2010;36: 1950-5.
38. Essers BA, van Helvoort-Postulart D, Prins MH, Neuman M. Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma? A comparison of two discrete-choice experiments. Pharmacoeconomics 2010;29:507-20.